Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy.
about
Recent developments in human immunodeficiency virus-1 latency researchLentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates.Bioinformatic analysis of HIV-1 entry and pathogenesis.Eradication therapies for HIV Infection: time to begin again.HIV persistence: chemokines and their signalling pathways.Finding a cure for HIV: will it ever be achievable?Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies.Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cellsTowards an HIV cure: a global scientific strategySingle cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule.Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells.Eradicating HIV-1 infection: seeking to clear a persistent pathogen.Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy.Role of Bruton's tyrosine kinase inhibitors in HIV-1-infected cellsImpaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ARTHIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells.Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1.HIV RNA suppression and immune restoration: can we do better?HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells.Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradicationPersistent Simian Immunodeficiency Virus Infection Drives Differentiation, Aberrant Accumulation, and Latent Infection of Germinal Center Follicular T Helper CellsHIV reservoirs and latency models.Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.HIV-1 transcription and latency: an update.Altering cell death pathways as an approach to cure HIV infection.Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.Broad activation of latent HIV-1 in vivo.Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.Susceptibility to CD8 T-cell-mediated killing influences the reservoir of latently HIV-1-infected CD4 T cellsHomeostatically Maintained Resting Naive CD4+ T Cells Resist Latent HIV Reactivation.HIV-1 Latency and Eradication: Past, Present and FutureHIV-1 Reservoirs During Suppressive Therapy.HIV reservoirs and strategies for eradication.Achieving a cure for HIV infection: do we have reasons to be optimistic?Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials.Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.Paediatric HIV infection: the potential for cure.Comorbidities associated with HIV and antiretroviral therapy (clinical sciences): a workshop report.
P2860
Q27013114-59AB9715-4D02-42AD-856B-2E8DFD467D12Q27318042-6421F03F-B543-49FC-AB24-DD9DC8468C7FQ27693321-4500762D-2288-41C9-8F2B-273E31792A1BQ30399588-89B8A9F4-BD4E-4427-BAF0-314B94374825Q33774665-70DC88E8-0CCC-4AD9-B097-7AEF4CF55C18Q34567084-EF15EA7C-EBE5-4F50-AFBE-31448E6DBC67Q34593784-42616722-7224-4B10-B18E-A9045B560083Q34594969-E260B78D-6400-4300-A29C-7500A889C15CQ34640562-69F02FB4-F47D-4B41-9A95-05FECA5FE920Q34789289-F69A38B2-10C4-4884-99F3-DCA31EF8CAD9Q35067224-964C88F0-3C82-4F58-9581-CFCA9E9411E7Q35252186-67AEF744-C94E-4B85-AC8B-8DEBEB98960AQ35436367-CC5E965F-F96F-4B85-9E19-D716229788C2Q35612194-8E15F53D-5DBB-464A-9CCB-4AB4A1991A07Q35626699-A9889788-6011-4582-9B6F-802342C9818CQ35661660-23E4498E-F517-4E1B-8421-37740BCC71DBQ35856911-8D41142A-F542-4B72-BA9B-9BE96B8CA444Q35867173-8FE9DC8A-6260-42CB-8AFF-F92AEC4E4965Q36121883-ADF324C1-EF93-42A9-B60F-29B08409F810Q36202761-38B321B9-A0D6-4D1A-B664-D0FD45EAC249Q36330062-40D59D3A-E181-460A-B61C-AF76DD153B98Q36481555-3AFB14C7-5497-495E-8D6E-44017F88C177Q36746403-4650633E-FEE3-4BB3-82DB-BE3844B9E287Q36957851-2D8464C7-173A-4580-A7A1-D7267CA9EFF8Q36976156-792051FF-37EE-45AA-A48D-1C7FE492BE8FQ37062057-5E654C2F-4609-4F48-B5DA-547F6AC94FE5Q37145779-D8F57D6D-45BD-4782-A352-56FCD308E925Q37260309-CA8CFA9E-9B27-4AF4-AE11-BC993BCBD76BQ37413059-42595343-497B-4606-8BEE-0DFBCEA5C736Q37417614-5F7BBED4-CA2F-4D92-8FD4-843E0BFD8229Q37459228-35096845-1C38-4A79-ABD4-48F62A2D80E7Q37505823-C34EA07B-E19C-452D-BEBF-B1A43B6A23A0Q37656766-715DF1DF-846B-4F14-9070-1420880CF8A2Q37976293-D71866EA-0888-4C22-B2C9-17CE257E72FEQ37980423-1669EB53-34F7-4937-A60A-A9797775F1CBQ38078562-C02A524B-61A5-437F-9774-DC5D1E4F1142Q38096822-57BFBB68-1DE6-4723-B8FD-64462B77B19DQ38662748-FC506C8F-8229-4753-8B27-A4571E6F91CBQ38773102-122E8168-D063-4353-B99A-85BADE443252Q38876754-2AE20E8F-A22F-4937-8556-46AEB4897FD1
P2860
Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Both CD31
@nl
Both CD31(+) and CD31⁻ naive C ...... eiving antiretroviral therapy.
@en
type
label
Both CD31
@nl
Both CD31(+) and CD31⁻ naive C ...... eiving antiretroviral therapy.
@en
prefLabel
Both CD31
@nl
Both CD31(+) and CD31⁻ naive C ...... eiving antiretroviral therapy.
@en
P2093
P50
P356
P1476
Both CD31(+) and CD31⁻ naive C ...... eiving antiretroviral therapy.
@en
P2093
Ajantha Solomon
Gabriela Khoury
Justin A Green
Nitin K Saksena
Paul R Gorry
Paul U Cameron
Suzanne M Crowe
Yung Shwen Ho
P304
P356
10.1086/656721
P407
P577
2010-10-27T00:00:00Z